Driving HIV-1 into a Vulnerable Corner by Taking Advantage of Viral Adaptation and Evolution
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Driving HIV-1 into a Vulnerable Corner by Taking Advantage of Viral Adaptation and Evolution
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 08, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-03-16
DOI
10.3389/fmicb.2017.00390
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
- (2016) Dennis R. Burton et al. Annual Review of Immunology
- A minimally cytotoxic CD4 mimic as an HIV entry inhibitor
- (2016) Takaaki Mizuguchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors
- (2016) Nami Ohashi et al. ChemMedChem
- Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds
- (2016) Navid Madani et al. JOURNAL OF VIROLOGY
- Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds
- (2016) Navid Madani et al. JOURNAL OF VIROLOGY
- Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption
- (2016) Katharine J. Bar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
- (2016) R. Kong et al. SCIENCE
- Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition
- (2016) Bruno Melillo et al. ACS Medicinal Chemistry Letters
- An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
- (2016) Marit J. van Gils et al. Nature Microbiology
- Passive transfer of neutralizing mAb KD-247 reduces plasma viral load in patients chronically infected with HIV-1
- (2015) Shuzo Matsushita et al. AIDS
- Dolutegravir inhibits HIV-1 Env evolution in primary human cells
- (2015) Thibault Mesplède et al. AIDS
- Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies
- (2015) Takeo Kuwata et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Virological failure of patients on maraviroc-based antiretroviral therapy
- (2015) S. Raymond et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
- (2015) Marina Caskey et al. NATURE
- AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
- (2015) Matthew R. Gardner et al. NATURE
- Antibody responses to envelope glycoproteins in HIV-1 infection
- (2015) Dennis R Burton et al. NATURE IMMUNOLOGY
- CD4 mimetics sensitize HIV-1-infected cells to ADCC
- (2015) Jonathan Richard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
- (2015) Rebecca M. Lynch et al. Science Translational Medicine
- Structure-Based Design, Synthesis and Validation of CD4-Mimetic Small Molecule Inhibitors of HIV-1 Entry: Conversion of a Viral Entry Agonist to an Antagonist
- (2014) Joel R. Courter et al. ACCOUNTS OF CHEMICAL RESEARCH
- Binding Mode Characterization of NBD Series CD4-Mimetic HIV-1 Entry Inhibitors by X-Ray Structure and Resistance Study
- (2014) Francesca Curreli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Impact of maraviroc-resistant and low-CCR5-adapted mutations induced by in vitro passage on sensitivity to anti-envelope neutralizing antibodies
- (2014) K. Yoshimura et al. JOURNAL OF GENERAL VIROLOGY
- Drift of the HIV-1 Envelope Glycoprotein gp120 toward Increased Neutralization Resistance over the Course of the Epidemic: a Comprehensive Study Using the Most Potent and Broadly Neutralizing Monoclonal Antibodies
- (2014) M. Bouvin-Pley et al. JOURNAL OF VIROLOGY
- CD4-Mimetic Small Molecules Sensitize Human Immunodeficiency Virus to Vaccine-Elicited Antibodies
- (2014) N. Madani et al. JOURNAL OF VIROLOGY
- Crystal Structures of HIV-1 gp120 Envelope Glycoprotein in Complex with NBD Analogues That Target the CD4-Binding Site
- (2014) Young Do Kwon et al. PLoS One
- CD4 mimics as HIV entry inhibitors: Lead optimization studies of the aromatic substituents
- (2013) Tetsuo Narumi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Impact of antiretroviral pressure on selection of primary human immunodeficiency virus type 1 envelope sequences in vitro
- (2013) S. Harada et al. JOURNAL OF GENERAL VIROLOGY
- Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
- (2013) Hua-Xin Liao et al. NATURE
- A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations
- (2013) Michael Roche et al. Retrovirology
- Structure-Based Design and Synthesis of an HIV-1 Entry Inhibitor Exploiting X-ray and Thermodynamic Characterization
- (2013) Judith M. LaLonde et al. ACS Medicinal Chemistry Letters
- Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
- (2012) Peter D. Kwong et al. IMMUNITY
- Structure-Based Design, Synthesis, and Characterization of Dual Hotspot Small-Molecule HIV-1 Entry Inhibitors
- (2012) Judith M. LaLonde et al. JOURNAL OF MEDICINAL CHEMISTRY
- HIV-1 Resistance to Maraviroc Conferred by a CD4 Binding Site Mutation in the Envelope Glycoprotein gp120
- (2012) A. N. Ratcliff et al. JOURNAL OF VIROLOGY
- Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
- (2012) Penny L Moore et al. NATURE MEDICINE
- MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
- (2012) Katrijn Grupping et al. Retrovirology
- MiniCD4 Microbicide Prevents HIV Infection of Human Mucosal Explants and Vaginal Transmission of SHIV162P3 in Cynomolgus Macaques
- (2012) Nathalie Dereuddre-Bosquet et al. PLoS Pathogens
- Small molecular CD4 mimics as HIV entry inhibitors
- (2011) Tetsuo Narumi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- HIV-1 Clinical Isolates Resistant to CCR5 Antagonists Exhibit Delayed Entry Kinetics That Are Corrected in the Presence of Drug
- (2011) O. Putcharoen et al. JOURNAL OF VIROLOGY
- HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry
- (2011) Michael Roche et al. Retrovirology
- Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screening
- (2010) Judith M. LaLonde et al. BIOORGANIC & MEDICINAL CHEMISTRY
- CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist
- (2010) Tetsuo Narumi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Enhanced Exposure of Human Immunodeficiency Virus Type 1 Primary Isolate Neutralization Epitopes through Binding of CD4 Mimetic Compounds
- (2010) K. Yoshimura et al. JOURNAL OF VIROLOGY
- A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5
- (2010) John C. Tilton et al. JOURNAL OF VIROLOGY
- HIV-1 Resistance to CCR5 Antagonists Associated with Highly Efficient Use of CCR5 and Altered Tropism on Primary CD4+ T Cells
- (2010) J. M. Pfaff et al. JOURNAL OF VIROLOGY
- CD4 mimics targeting the mechanism of HIV entry
- (2009) Yuko Yamada et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Adaptive Mutations in a Human Immunodeficiency Virus Type 1 Envelope Protein with a Truncated V3 Loop Restore Function by Improving Interactions with CD4
- (2009) C. Agrawal-Gamse et al. JOURNAL OF VIROLOGY
- Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
- (2009) M. S. Seaman et al. JOURNAL OF VIROLOGY
- Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities
- (2009) Pavel Pugach et al. VIROLOGY
- Two HIV-1 Variants Resistant to Small Molecule CCR5 Inhibitors Differ in How They Use CCR5 for Entry
- (2009) Reem Berro et al. PLoS Pathogens
- Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State
- (2009) Hillel Haim et al. PLoS Pathogens
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
- (2008) Roy M. Gulick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Small-Molecule CD4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp120
- (2008) Navid Madani et al. STRUCTURE
- Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors
- (2008) Pavel Pugach et al. VIROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started